Catalyst Wire Dossier Catalyst Wire Dossier

CT-P53

CT-P53 · Celltrion
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT-P53, covering 2024-05-22 to 2024-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis [Phase 3]

See pricing